Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Stefan, Madajewicz"'
Autor:
Yue Zhang, Kevin Zarrabi, Wei Hou, Stefan Madajewicz, Minsig Choi, Stanley Zucker, Wen-Tien Chen
Publikováno v:
Biomedicines, Vol 6, Iss 2, p 69 (2018)
Colorectal carcinoma (CRC) is the second leading cause of cancer-related mortality. The goals of this study are to evaluate the association between levels of invasive circulating tumor cells (iCTCs) with CRC outcomes and to explore the molecular char
Externí odkaz:
https://doaj.org/article/2143da1d472041f1b3245ba8e6f2cbc2
Autor:
Patricia Hentschel, John F. Gill, Paul S. Ritch, Sandeep K. Malik, C. G. Leichman, Stefan Madajewicz, Donald J. Higby, M Qaseem Khan, Luping Zhao, David M. Waterhouse, Steven J. Nicol
Publikováno v:
Investigational New Drugs. 30:772-778
Purpose To assess safety and efficacy of folinic acid, 5-fluorouracil, gemcitabine (FFG) and folinic acid, fluorouracil, oxaliplatin (FOLFOX4) regimens with added bevacizumab as first-line treatment in patients with advanced colorectal cancer (CRC).
Autor:
Stanley Zucker, Wen-Tien Chen, Stefan Madajewicz, Kevin Zarrabi, Yue Zhang, Minsig Choi, Wei Hou
Publikováno v:
Biomedicines
Volume 6
Issue 2
Biomedicines, Vol 6, Iss 2, p 69 (2018)
Volume 6
Issue 2
Biomedicines, Vol 6, Iss 2, p 69 (2018)
Colorectal carcinoma (CRC) is the second leading cause of cancer-related mortality. The goals of this study are to evaluate the association between levels of invasive circulating tumor cells (iCTCs) with CRC outcomes and to explore the molecular char
Autor:
Tina Fan, Wen-Tien Chen, Stefan Madajewicz, Wei Zeng, Marc G. Golightly, Qiang Zhao, Michael A. Frohman, Eva Zaslavsky, Janice Lu, John J. Chen
Publikováno v:
International Journal of Cancer. 126:669-683
Recent research advances show that tumor cell intravasation (entry into the circulation) and metastasis occur very early in breast cancer progression. Clinical studies also illustrate the potential importance of detection of circulating tumor cells (
Autor:
K. F. Liau, John D. Hainsworth, Thomas Michael Cosgriff, Kristen J. Pierce, Diane Healey, Peter D. Eisenberg, George R. Simon, Stefan Madajewicz, Corey J. Langer, Huiping Xu, Roger B. Cohen
Publikováno v:
Cancer Chemotherapy and Pharmacology. 60:81-89
To evaluate the toxicity profile and pharmacological properties of oral CP-547,632 alone and in combination with paclitaxel and carboplatin administered every 3 weeks, and to assess efficacy as measured by the objective response and progressive disea
Publikováno v:
Community Oncology. 3:678-683
Autor:
Lakshmi Pendyala, Noshir A. DaCosta, John J. Fiore, William G. Abel, Daniele Matei, Andrzej P. Kudelka, Stefan Madajewicz, Patricia Hentschel
Publikováno v:
Cancer Investigation. 17:463-467
Patients with stage IIIB breast carcinoma represent only a small proportion of women with breast cancer in western countries but may constitute up to 50% of cases in underdeveloped countries. The prognosis remains poor despite aggressive treatment. N
Autor:
Sharon Yee, Randi Isaacs, Eric P. Lester, Eric Chevlen, Michael Ames, Thomas M. Beck, Jim H. Harvey, Howard D. Homesley, Stefan Madajewicz, Mary R. Creed, N. Simon Tchekmedyian, David Sciortino, Karen H. Crawford, William Whaley, Jesse I. Spector
Publikováno v:
The Oncologist. 3:432-438
Purpose: To compare the efficacy and safety of oral ondansetron with i.v. granisetron each given as a single dose prior to administration of highly emetogenic cisplatin chemotherapy. Patients and Methods: Chemotherapy-naive patients with histological
Autor:
Patricia Roche, James Manzione, Clemente Roque, Arafat Tfayli, Stefan Madajewicz, Maisie L. Shindo
Publikováno v:
Seminars in Interventional Radiology. 15:365-371
Autor:
Thomas M. Beck, B Greenberg, N S Tchekmedyian, Rudolph M. Navari, K C Caldwell, H Garewal, Stefan Madajewicz, N Anderson, W Whaley, A Y Chang
Publikováno v:
Journal of Clinical Oncology. 13:2408-2416
PURPOSE To investigate the efficacy and safety of oral ondansetron in the control of cisplatin-induced delayed emesis in patients who do not require rescue antiemetic therapy for acute emesis. PATIENTS AND METHODS Five hundred thirty-eight chemothera